Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond von Kudo, Masatoshi

Volltext

Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials von Kudo, Masatoshi

Volltext

Systemic Therapy for Hepatocellular Carcinoma: Latest Advances von Kudo, Masatoshi

Volltext

Systemic Therapy for Hepatocellular Carcinoma: 2017 Update von Kudo, Masatoshi

Volltext

Immuno-Oncology in Hepatocellular Carcinoma: 2017 Update von Kudo, Masatoshi

Volltext

Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update von Kudo, Masatoshi

Volltext

New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma von Kudo, Masatoshi

Volltext

A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion von Kudo, Masatoshi

Volltext

Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma von Kudo, Masatoshi

Volltext

Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma von Kudo, Masatoshi

Volltext

Surveillance, Diagnosis, Treatment, and Outcome of Liver Cancer in Japan von Kudo, Masatoshi

Volltext

Newly Developed Modified ALBI Grade Shows Better Prognostic and Predictive Value for Hepatocellular Carcinoma von Kudo, Masatoshi

Volltext

Changing the Treatment Paradigm for Hepatocellular Carcinoma Using Atezolizumab plus Bevacizumab Combination Therapy von Kudo, Masatoshi

Volltext

Multistep human hepatocarcinogenesis: correlation of imaging with pathology von Kudo, Masatoshi

Volltext

Gd-EOB-DTPA-MRI Could Predict WNT/β-Catenin Mutation and Resistance to Immune Checkpoint Inhibitor Therapy in Hepatocellular Carcinoma von Kudo, Masatoshi

Volltext

A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy von Kudo, Masatoshi

Volltext

Radiofrequency Ablation for Hepatocellular Carcinoma: Updated Review in 2010 von Kudo, Masatoshi

Volltext

Management of Hepatocellular Carcinoma in Japan as a World-Leading Model von Kudo, Masatoshi

Volltext

Extremely High Objective Response Rate of Lenvatinib: Its Clinical Relevance and Changing the Treatment Paradigm in Hepatocellular Carcinoma von Kudo, Masatoshi

Volltext

Immuno-Oncology Therapy for Hepatocellular Carcinoma: Current Status and Ongoing Trials von Kudo, Masatoshi

Volltext